The Health Product Vigilance Framework is being developed to strengthen and modernize health product vigilance (PV) practices in Canada. Aligned with the Federal Regulatory Post-Market Surveillance Strategy, this framework will optimize resources by focusing on higher risk products through standardized prioritization policies and will implement a vigilance framework that manages risks consistently across product lines. It will emphasize industry's vigilance responsibilities, consistent with international harmonization objectives, wherever possible, and will integrate the use of product vigilance tools across product lines and throughout a product's lifecycle.